Global Biliary Atresia Treatment Market Size, Share, and COVID-19 Impact Analysis By Disease Type (Type I, Type II, and Type III), By Drugs ( Corticosteroids, Bile Acids Analogues, Antibiotics, Others), By Route of Administration (Oral, Parenteral), By End-Users (Homecare, Hospitals, Specialty Clinics, Others), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030

Industry: Healthcare
RELEASE DATE Oct 2022
REPORT ID SI1196
PAGES 240
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Disease Type
      2. Market Attractiveness Analysis By Drugs Type
      3. Market Attractiveness Analysis By Route of Administration
      4. Market Attractiveness Analysis By Distribution Channel
      5. Market Attractiveness Analysis By End-Users
      6. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increase in the number of research and development activities 
    3. Restraints
      1. Complications of Biliary Atresia Drugs
    4. Opportunities
      1. Increasing Demand for Retail Pharmacies
    5. Challenges
      1. Unavailability of Appropriate Treatments
  6. Global Biliary Atresia Treatment Analysis and Projection, By Disease Type 
    1. Segment Overview
    2. Type I
    3. Type ll
    4. Type lll
  7. Global Biliary Atresia Treatment Analysis and Projection, By Drugs Type 
    1. Segment Overview
    2. Corticosteroids
    3. Bile Acids Analogues
    4. Antibiotics
    5. Others
  8. Global Biliary Atresia Treatment Analysis and Projection, By Route of Administration
    1. Segment Overview
    2. Oral
    3. Parenteral
  9. Global Biliary Atresia Treatment Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Online Pharmacies
    3. Hospital Pharmacies
    4. Retail Pharmacies
  10. Global Biliary Atresia Treatment Analysis and Projection, By End-Users
    1. Segment Overview
    2. Homecare
    3. Hospitals
    4. Specialty Clinics
    5. Others
  11. Global Biliary Atresia Treatment Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  12. Global Biliary Atresia Treatment-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Biliary Atresia Treatment
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  13. Company Profiles
    1. F. Hoffmann-La Roche Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. Mylan N.V.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3. Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5. AstraZeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. Johnson & Johnson Private Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. Sun Pharmaceutical Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Bristol-Myers Squibb Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. Lilly
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10. Amgen Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  2. Global Type I Biliary Atresia Treatment, Region, 2021-2030(USD Billion)
  3. Global Type ll Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  4. Global Typelll Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  5. Global Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  6. Global Corticosteroids Biliary Atresia Treatment, Region, 2021-2030(USD Billion)
  7. Global Bile Acids Analogues Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  8. Global AntibioticsBiliary Atresia Treatment, Region, 2021-2030(USD Billion)
  9. Global Others Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  10. Global Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  11. Global Oral Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  12. Global Parenteral Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  13. Global Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  14. Global Online Pharmacies Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  15. Global Hospital Pharmacies Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  16. Global Retail Pharmacies Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  17. Global Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  18. Global Homecare Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  19. Global Hospitals Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  20. Global Specialty Clinics Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  21. Global Others Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  22. Global Biliary Atresia Treatment, By Region, 2021-2030(USD Billion)
  23. North America Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  24. North America Biliary Atresia Treatment,By Drugs Type, 2021-2030(USD Billion)
  25. North America Biliary Atresia Treatment,By Route of Administration, 2021-2030(USD Billion)
  26. North America Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  27. North America Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  28. U.S. Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  29. U.S. Biliary Atresia Treatment,By Drugs Type, 2021-2030(USD Billion)
  30. U.S. Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  31. U.S. Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  32. U.S. Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  33. Canada Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  34. Canada Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  35. Canada Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  36. Canada Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  37. Canada Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  38. Mexico Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  39. Mexico Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  40. Mexico Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  41. Mexico Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  42. Mexico Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  43. Europe Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  44. Europe Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  45. Europe Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  46. Europe Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  47. Europe Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  48. Germany Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  49. Germany Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  50. Germany Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  51. Germany Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  52. Germany Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  53. France Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  54. France Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  55. France Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  56. France Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  57. France Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  58. U.K. Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  59. U.K. Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  60. U.K. Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  61. U.K. Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  62. U.K. Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  63. Italy Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  64. Italy Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  65. Italy Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  66. Italy Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  67. Italy Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  68. Spain Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  69. Spain Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  70. Spain Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  71. Spain Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  72. Spain Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  73. Asia Pacific Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  74. Asia Pacific Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  75. Asia Pacific Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  76. Asia Pacific Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  77. Asia Pacific Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  78. Japan Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  79. Japan Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  80. Japan Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  81. Japan Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  82. Japan Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  83. China Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  84. China Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  85. China Biliary Atresia Treatment,By Route of Administration, 2021-2030(USD Billion)
  86. China Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  87. China Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  88. India Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  89. India Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  90. India Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  91. India Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  92. India Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  93. South America Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  94. South America Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  95. South America Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  96. South America Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  97. South America Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)  
  98. Brazil Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  99. Brazil Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  100. Brazil Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  101. Brazil Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  102. Brazil Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  103. The Middle East and Africa Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  104. The Middle East and Africa Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  105. The Middle East and Africa Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  106.  The Middle East and Africa Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  107. The Middle East and Africa Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  108. UAE Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  109. UAE Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  110. UAE Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  111. UAE Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  112. UAE Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)
  113. South Africa Biliary Atresia Treatment, By Disease Type, 2021-2030(USD Billion)
  114. South Africa Biliary Atresia Treatment, By Drugs Type, 2021-2030(USD Billion)
  115. South Africa Biliary Atresia Treatment, By Route of Administration, 2021-2030(USD Billion)
  116. South Africa Biliary Atresia Treatment, By Distribution Channel, 2021-2030(USD Billion)
  117. South Africa Biliary Atresia Treatment, By End-Users, 2021-2030(USD Billion)

 

List of Figures 

  1. Global Biliary Atresia Treatment Segmentation
  2. Biliary Atresia Treatment: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-Down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Biliary Atresia Treatment
  9. Top Winning Strategies, 2021-2030
  10. Top Winning Strategies, By Development, 2021-2030(%)
  11. Top Winning Strategies, By Company, 2021-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers: Biliary Atresia Treatment
  20. Biliary Atresia Treatment Segmentation, By Disease Type
  21. Biliary Atresia Treatment For Type I, By Disease Type, 2022-2030 ($Billion)
  22. Biliary Atresia Treatment For Type ll, By Disease Type, 2022-2030 ($Billion)
  23. Biliary Atresia Treatment ForType lll, By Disease Type, 2022-2030 ($Billion)
  24. Biliary Atresia Treatment Segmentation, By Drugs Type
  25. Biliary Atresia Treatment For Corticosteroids, By Drugs Type, 2022-2030 ($Billion)
  26. Biliary Atresia Treatment For Bile Acids Analogues, By Drugs Type, 2022-2030 ($Billion)
  27. Biliary Atresia Treatment For Antibiotics, By Drugs Type, 2022-2030 ($Billion)
  28. Biliary Atresia Treatment For Others, By Drugs Type, 2022-2030 ($Billion)
  29. Biliary Atresia Treatment Segmentation, By Route of Administration, 2022-2030 ($Billion)
  30. Biliary Atresia Treatment For Domestic, By Route of Administration, 2022-2030 ($Billion)
  31. Biliary Atresia Treatment For Parenteral, By Route of Administration, 2022-2030 ($Billion)
  32. Biliary Atresia Treatment Segmentation, By Distribution Channel
  33. Biliary Atresia Treatment For Online Pharmacies, By Distribution Channel, 2022-2030 ($Billion)
  34. Biliary Atresia Treatment For Hospital Pharmacies, By Distribution Channel, 2022-2030 ($Billion)
  35. Biliary Atresia Treatment For Retail Pharmacies, By Distribution Channel 2022-2030 ($Billion)
  36. Biliary Atresia Treatment Segmentation, By End-Users
  37. Biliary Atresia Treatment for Homecare, By End-Users, 2022-2030 ($Billion)
  38. Biliary Atresia Treatment for Hospitals, By End-Users, 2022-2030 ($Billion)
  39. Biliary Atresia Treatment For Specialty Clinics, By End-Users, 2022-2030 ($Billion)
  40. Biliary Atresia Treatment For Others, By End-Users, 2022-2030 ($Billion)
  41. FedEx Corporation: Net Sales, 2021-2030 ($Billion)
  42. FedEx Corporation: Revenue Share, By Segment, 2022 (%)
  43. FedEx Corporation: Revenue Share, By Region, 2022 (%)
  44. DHL International GmbH: Net Sales, 2021-2030 ($Billion)
  45. DHL International GmbH: Revenue Share, By Segment, 2022 (%)
  46. DHL International GmbH: Revenue Share, By Region, 2022 (%)
  47. XPO Logistics Plc.: Net Sales, 2021-2030 ($Billion)
  48. XPO Logistics Plc.: Revenue Share, By Segment, 2022 (%)
  49. XPO Logistics Plc.: Revenue Share, By Region, 2022 (%)
  50. Aramex International: Net Sales, 2021-2030 ($Billion)
  51. Aramex International: Revenue Share, By Segment, 2022 (%)
  52. Aramex International: Revenue Share, By Region, 2022 (%)
  53. United Parcel Service, Inc.: Net Sales, 2021-2030 ($Billion)
  54. United Parcel Service, Inc.: Revenue Share, By Segment, 2022 (%)
  55. United Parcel Service, Inc.: Revenue Share, By Region, 2022 (%)
  56. Gati Limited: Net Sales, 2021-2030 ($Billion)
  57. Gati Limited: Revenue Share, By Segment, 2022 (%)
  58. Gati Limited: Revenue Share, By Region, 2022 (%)
  59. Kenco Group, Inc..: Net Sales, 2021-2030 ($Billion)
  60. Kenco Group, Inc..: Revenue Share, By Segment, 2022 (%)
  61. Kenco Group, Inc..: Revenue Share, By Region, 2022 (%)
  62. Clipper Logistics Plc.: Net Sales, 2021-2030 ($Billion)
  63. Clipper Logistics Plc.: Revenue Share, By Segment, 2022 (%)
  64. Clipper Logistics Plc.: Revenue Share, By Region, 2022 (%)
  65. Agility Public Warehousing Company K.S.C.P.: Net Sales, 2021-2030 ($Billion)
  66. Agility Public Warehousing Company K.S.C.P.: Revenue Share, By Segment, 2022 (%)
  67. Agility Public Warehousing Company K.S.C.P.: Revenue Share, By Region, 2022 (%)
  68. CEVA Logistics: Net Sales, 2021-2030 ($Billion)
  69. CEVA Logistics: Revenue Share, By Segment, 2022 (%)
  70. CEVA Logistics: Net Sales, 2021-2030 ($Billion)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:187
Pages:240
Countries covered:16
Companies covered::14
Forecast CAGR:7.2%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies